萬馬科技(300698.SZ):上海優咔與麗台科技簽署戰略合作框架協議
格隆匯6月24日丨萬馬科技(300698.SZ)公佈,近日,萬馬科技股份有限公司全資子公司上海優咔網絡科技有限公司(簡稱“上海優咔”)與麗台(上海)信息科技有限公司(簡稱“麗台科技”)簽署《戰略合作框架協議》。為加強雙方合作,經過友好協商,雙方以各自在專業領域的多年沉澱,建立戰略合作伙伴關係。雙方在英偉達的協助下,為行業客户提供先進的AI企業軟件產品,三方在人工智能算力建設的基礎上開展全方位合作,強強聯合,互惠互利,共創共贏,實現共同發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.